In reports where LSECs secreted high levels of SphK1 in exosomes in CCl4-induced hepatic fibrosis, facts were demonstrated that Sal was able to hamper LX-2 activation by SphK1 in exosomes via blocking the activation of the AKT pathway (Ye et al., 2021). Here, SPHK1 is linked to Hepatic fibrosis.